Tamoxifen is another classic SERM, for decades used as a frontline therapy in hormone-receptor-positive breast cancer. In performance circles it is used both for gynaecomastia management and in certain PCT protocols. Kohoh’s Novalin offers tamoxifen in oral tablet form.
──────────────────
📌Key benefit
•Blocks oestrogen receptors in breast tissue, helping manage or reduce gynaecomastia-type symptoms.
•💪🏻Supports post-cycle hormonal recovery as part of a PCT strategy.
•🧬May help keep cholesterol levels more stable compared to some aromatase inhibitors, although blood work is still essential.
──────────────────
🎯Recommended for
•Users who are prone to gynaecomastia and are under guidance to manage oestrogen.
•Individuals planning a structured PCT after a cycle.
•⚠️Not a general “fat-loss” or “muscle” drug and not for unsupervised long-term use.
Reviews
There are no reviews yet.